Johnson & Johnson Net Worth 2006-2018 | JNJ

Interactive chart of historical net worth (market cap) for Johnson & Johnson (JNJ) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Johnson & Johnson net worth as of January 22, 2019 is $345.56B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $345.558B $81.581B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Pfizer (PFE) United States $251.628B 14.19
Merck (MRK) United States $204.452B 17.72
Novartis AG (NVS) Switzerland $204.019B 17.49
AbbVie (ABBV) United States $133.364B 11.84
Eli Lilly (LLY) United States $124.036B 21.80
Novo Nordisk (NVO) Denmark $117.754B 19.12
Sanofi (SNY) France $104.061B 12.89
GlaxoSmithKline (GSK) United Kingdom $96.669B 12.99
AstraZeneca (AZN) United Kingdom $91.868B 11.41
Bristol-Myers Squibb (BMY) United States $81.153B 13.37